Skip to main content
Caplight Logo









Phyla

Phyla

Private
Petaluma, CaliforniaConsumer & Commercehttps://phyla.com/

Last Round

Series A

Jun 26, 2024

Est. Valuation

$16.16M

Total Funding Raised

$8.24M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Phyla is a personal products company that operates a skincare platform utilizing microbiome and bacteriophage technology to treat acne.

Sector

Consumer & Commerce

Verticals

Biotechnology, Fashion & Beauty, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Non-AI

Keywords

bacteriophage technologyacne treatmentphage technologymicrobiome skincareskin microbiomephage therapybiotechnologyDTC skincaredirect-to-consumersubscription commerceprobiotic skincaretopical treatmentAcne Phage SerumB2B2C

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phyla Comparables

Compare Phyla with similar companies based on industry and business-model similarity.

Phyla comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ellis Day Skin Science
89%
Dermala Inc.
79%
Sofie Pavitt Face
79%

Phyla Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 26, 2024
Corporate FundingDec 11, 2023
VC RoundJul 13, 2022
SeedJun 4, 2019

Key People

Founding team and executive leadership

Yug Varma

Founder & CTO

Founding Team

Neil Giugno

CEO

Executive Team

Phyla Investors

Notable investors and investment history

Phyla investors
InvestorRounds
AimTop VenturesSeed
Progression FundVC Round, Series A
ShiseidoCorporate Funding
Joyance PartnersSeed, VC Round, Series A
Maximum Effort HoldingsVC Round
Social StartsSeed
Willow Growth PartnersVC Round, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 88% MoM, reaching 34.7K.

  • Jun 21, 2026

    Monthly visitors increased 61% MoM.

Phyla Filings

Explore SEC and related filing metadata, where available.

Phyla filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Phyla's valuation, stock price, and market status.

Is Phyla a public or private company?

Phyla is a private company.

What is the current stock price of Phyla?

Phyla is a private company with no public stock price. No recent secondary market data is available.

How much is Phyla worth (valuation)?

Phyla's valuation is estimated at $16.2M based on funding round data.

Can I buy Phyla stock?

Phyla shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Phyla's last funding round?

Phyla's most recent funding round was Series A on June 26, 2024.

Who are the main investors in Phyla?

Investor information for Phyla is not publicly disclosed.

Will Phyla IPO soon?

No public IPO plans have been announced for Phyla.

How can I track Phyla secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phyla's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPetaluma, California
Employee Range12
Year Founded2019
Last FundingJun 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?